Physician profile
Zachery Baxter
NPI 1538371679
$2,842.61
in general payments reported to CMS, 2019-2025
15 companies · $114 in 2025
The $114 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $633 · 2020: $221 · 2021: $115 · 2022: $457 · 2023: $1,007 · 2024: $296 · 2025: $114.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,417.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,416.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $761.73 | 2019-2020 | |
| Abbvie INC. | $542.15 | 2022-2025 | Botox |
| Medtronic, INC. | $372.72 | 2021-2025 | Interstim |
| Rochester Medical Corporation | $323.39 | 2021-2022 | |
| C. R. Bard, INC. & Subsidiaries | $255.21 | 2023-2025 | Bard Urinary Drainage Bag |
| Procept Biorobotics Corporation | $248.86 | 2023-2024 | Aquabeam Robotic System, Aquabeam System |
| Becton, Dickinson and Company | $93.34 | 2023-2024 | Bard Urinary Drainage Bag |
| Boston Scientific Corporation | $91.83 | 2019 | |
| Progenics Pharmaceuticals, INC. | $35.03 | 2021-2023 | Pylarify |
| Sumitomo Pharma America, INC. | $23.66 | 2025 | Gemtesa |
| Coloplast Corp | $22.54 | 2021 | |
| Hollister Incorporated | $19.54 | 2024 | Vapro |
| Abc Home Medical Supply, INC. | $19.54 | 2024 | |
| Urogen Pharma, INC. | $16.71 | 2023 | Jelmyto |
| Astellas Pharma US INC | $16.36 | 2023 | Myrbetriq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zachery Baxter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.